Multiple symmetrical lipomatosis (MSL) is a rare benign disorder characterized by multiple fatty masses (lipomas) that are located symmetrically on either side of the midline of the body, most commonly on the upper arms and thighs. Lipomatosis is a group of disorders associated with excess adipose tissue formation, and MSL is one of its most pronounced subtypes. The disorder can occur at any age, but is more common in middle-aged men. Lipomas associated with this disorder are usually soft to the touch, painless, and mobile relative to surrounding tissues, but in some cases they can cause cosmetic discomfort and limit mobility in connective tissues.
History of the disease and interesting historical facts
The history of multiple symmetrical lipomatosis goes back to early medical practice, when cases of multiple fatty formations were first described. One of the first works devoted to such a pathology was the publication of the German dermatologist Friedrich M. Lascha in 1951, which described in detail the symptoms and clinical aspects of the disease. Historical documents also contain references to similar cases in ancient Greek and Roman medicine, but they have not received detailed study as a separate pathology. It remains an interesting fact that for decades, MSL did not have a clear classification, and it was often confused with other forms of lipomatosis and lipoblastoma. In recent decades, there has been significant progress in understanding the molecular and genetic basis of this disease, which has contributed to a deeper study and understanding of its causes and mechanisms of development.
Epidemiology
According to epidemiological studies, the prevalence of multiple symmetrical lipomatosis is 1 to 3 cases per 100,000 population. This rare disease occurs in both men and women, but in most cases there is a predominance of men, which suggests a possible role of hormonal levels in its development. The pathology is most often diagnosed in patients aged 30 to 60 years, and the onset of the disease can be observed at a younger age. Multiple symmetrical lipomatosis can be found in all geographic regions, but reported cases often have associations with certain ethnic groups, which opens up opportunities for further research on genetic and environmental factors affecting the incidence of the disease.
Genetic predisposition to this disease
There are various hypotheses about the genetic predisposition to multiple symmetric lipomatosis. It is assumed that certain mutations in genes related to fat metabolism may increase the risk of developing this disease. In recent years, researchers have identified a link between MSL and mutations in genes such as FAT, CAV1, and PLIN1, which play an important role in the formation and metabolism of fat tissue. Cellular studies have shown altered expression of these genes in patients with MSL, which supports the basic concept that genetic factors may contribute to the predisposition to this disease. There are also cases of inheritance of the disease in families, which further indicates its genetic nature.
Risk factors for the development of this disease
Among the risk factors that contribute to the development of multiple symmetrical lipomatosis, both physical and chemical factors can be distinguished. Physical factors include:
- Overweight and obesity, which can contribute to metabolic disorders and excess adipose tissue formation.
- Soft tissue injuries that can cause stem cell dysfunction, leading to excess fat formation.
- Heredity, in particular the presence of lipomatosis in close relatives.
Chemical factors may include:
- Exposure to certain toxins and chemicals, such as vinyl chloride and some medications, which may cause disturbances in lipid metabolism as side effects.
- Hormonal changes, particularly levels of sex hormones, which are thought to influence the pattern of fat deposition in the body.
Diagnosis of this disease
Diagnosis of multiple symmetrical lipomatosis is based on clinical, laboratory and instrumental methods. The main symptoms of the disease are:
- The presence of multiple soft, mobile and painless fatty formations, symmetrically located on both sides of the body.
- Absence of systemic manifestations such as fever or weight loss.
- Cosmetic discomfort arising from the presence of fatty deposits.
Laboratory tests may include a complete blood count and biochemical parameters, which are usually within normal limits since MSL is a benign disease. Radiological examinations such as ultrasound and MRI are used to clarify the nature and depth of lipoma invasion. These examination methods allow differentiating lipomatosis from other tumor processes such as sarcoma or hemangioma, which is important for determining the appropriate treatment strategy. Differential diagnosis includes consideration of other forms of benign and malignant tumors of adipose tissue.
Treatment
Treatment of multiple symmetrical lipomatosis depends on the severity of the disease and the presence of symptoms. The main approaches include:
- Conservative treatment includes monitoring and control of the development of lipomas if they do not cause discomfort.
- Pharmacological treatment - local injection of steroids into lipomas can reduce their size, but this method is not always effective.
- Surgical intervention - removal of lipomas is indicated in case of significant cosmetic defect or limited mobility in the affected area.
- Minimally invasive techniques such as liposuction can be used to remove fatty deposits.
The combination of these treatment methods is selected individually for each patient, depending on the clinical situation and the patient's preferences.
List of medications used to treat this disease
There are currently no specific medications for the treatment of multiple symmetrical lipomatosis. However, among the drugs used, the following can be distinguished:
- Steroids (eg, triamcinolone) - for local injection into lipomas.
- Nonsteroidal anti-inflammatory drugs (ibuprofen, naproxen) - to reduce discomfort.
- Pharmacological agents for the correction of concomitant diseases such as obesity or metabolic disorders.
Disease monitoring
Monitoring the condition of multiple symmetrical lipomatosis includes regular check-ups with a doctor, which allow tracking changes in the condition of the lipomas and their impact on the patient's quality of life. Control stages may include:
- Regular ultrasound examinations to assess the size and structure of lipomas.
- General clinical studies to identify possible complications.
- Assessment of the quality of life and the dynamics of discomfort caused by the disease.
The prognosis with proper treatment is usually good, but the possibility of recurrence after lipoma removal should be taken into account. Complications can occur with inadequate treatment, which can lead to infections or scarring.
Age-related features of the disease
Multiple symmetrical lipomatosis can manifest itself at any age, but its features vary. In children, the disease usually has less pronounced symptoms and rarely requires active intervention. In adolescents and young adults, more aggressive forms may be observed, so it is important to conduct a thorough diagnosis. In adults, especially in the 30-60 age group, the disease is most often associated with metabolic disorders, while in older people, symptoms may gradually increase and require more attention from medical personnel and extensive treatment.
Questions and Answers
- What is multiple symmetrical lipomatosis? This is a rare disease characterized by multiple benign fatty formations located symmetrically on both sides of the body.
- What are the symptoms of multiple symmetrical lipomatosis? The main symptoms are the presence of soft, mobile and painless lipomas located on both sides of the body, without systemic manifestations.
- How is this disease diagnosed? Diagnosis is based on clinical examination, laboratory tests, ultrasound and MRI for differential diagnosis.
- How is multiple symmetrical lipomatosis treated? Treatment may include observation, surgery, and local injection of steroids into lipomas.
- What is the prognosis for multiple symmetrical lipomatosis? The prognosis with adequate treatment is usually favorable, but relapses are possible after surgery.
